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Introduction
Escherichia coli strains are implicated in a large number of 
extraintestinal infections (ExPEC) in humans such as urinary 
tract infection (UTI), bacteremia, pneumonia, soft-tissue 
infection, and neonatal meningitis.[1] Phylogenetic analysis 
has shown that E. coli strains fall into four main groups 
(A, B1, B2, and D). It has been found that pathogenic E. coli 
strains causing extraintestinal infections mainly belong to 
group B2 and a lesser extent to group D whereas commensal 
strains belong to group A and B1.[2] Results of various studies 
have also indicated that the phylogroups A and B1 (commensal 
strains) exhibit an increased drug resistance pattern but 
possess few virulence genes whereas the phylogroups B2 
and D (pathogenic strains) possess several pathogenicity 
associated islands and express multiple virulence factors 
such as adherence factors including biofilm production and 
high surface hydrophobicity, toxin (hemolysin and CNF) 
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Abstract
Background: Escherichia coli strains mainly fall into four phylogenetic groups (A, B1, B2, and D) 
and that virulent extra‑intestinal strains mainly belong to groups B2 and D. Aim: The aim was 
to determine the association between phylogenetic groups of E. coli causing extraintestinal 
infections (ExPEC) regarding the site of infection, expression of virulence factors, antimicrobial 
resistance patterns, and clinical outcome. This descriptive study was carried out in a 
multi‑specialty Tertiary Care Hospital. Materials and Methods: A total of 300 E. coli causing 
ExPEC were studied. Triplex polymerase chain reaction was used to classify the phylogenetic 
groups; hemolysin production was assessed on sheep blood agar and biofilm production 
in a microtiter plate assay. Production of extended spectrum of beta‑lactamase (ESBLs) 
was detected by combination disk method; AmpC was detected by AmpC disk test, 
Carbapenemase production was detected by modified Hodge test and metallo‑β‑lactamase 
by metallo‑beta‑lactamases (MBL) E‑test. Results: Of 300 isolates, 61/300 (20 %) belonged to 
phylogroup A, 27/300 (9%) to phylogroup B1, 104/300 (35%) were B2 and 108/300 (36%) 
belonged to group D, respectively. Phylogroups B2 and D were the most predominant groups 
in urinary tract infection and sepsis. Prognoses were better in infections with group A and B1 
isolates, and relapses and death were common in infections with B2 and D. Expression of biofilm 
was greatest in B1 and hemolysin in group B2. Group A and B1 showed higher resistance to 
ciprofloxacin and were most frequent β‑lactamase (ESBL, AmpC, Carbapenemase and MBL) 
producers. Conclusions: Phylogenetic group B2 and D were predominant in ExPEC and 
exhibited least antimicrobial resistance among the groups. Resistance to multiple antibiotics 
was most prevalent in group A and B1. Regular monitoring of antimicrobial susceptibility in 
commensal strains is essential as they might transfer the property of antimicrobial resistance 
to pathogenic strains.
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and siderophore production but are more susceptible to 
antibiotics.[3]
In recent years, much attention has been given to the analysis of 
the phylogenetic affiliation of pathogenic E. coli strains, so as 
to understand the sources of such ExPEC and also to limit the 
spread of multidrug resistance among such strains.[4] Although 
several studies have been reported from outside India, not 
much information is available regarding the phylogenetic 
lineage of ExPEC causing extraintestinal infections from 
within our country with only very few studies being reported 
regarding phylogenetic grouping. The aim of the present study 
was to assess the association between phylogenetic groups of 
E. coli and site of infection, phenotypic characters, antibiotic 
resistance, and clinical outcome, respectively.
Materials and Methods
Participants and clinical isolates
The study was conducted during the period from August 2010 
to January 2012, from hospitalized patients of two Tertiary 
Care Hospitals, after obtaining permission by way of informed 
consent from patients and ethical clearance from the Kasturba 
Medical College, Mangalore institutional ethical committee. 
Sample size was determined with 55% confidence and 90% 
power based on previous studies. Three hundred non-repeat 
strains of E. coli were isolated from specimen such as urine, 
blood, wound swab, pus, cerebrospinal fluid, ascitic fluid, 
and intravascular devices, collected using standard sterile 
procedures from the study population. The study population 
included hospitalized patients of all age groups whose 
extraintestinal clinical samples grew E. coli and excluded 
those subjects who had received antimicrobial drugs during 
the past 1 month, who had asymptomatic UTI, polymicrobial 
infections and those who were discharged without treatment 
with antimicrobial drugs. Clinical data from the patient’s 
records were collected in a proforma. All patients were 
followed up for the period of 1 year to monitor clinical 
outcome. The samples were processed immediately using 
standard procedures. The isolates were identified based on 
colony morphology on Blood agar, MacConkey’s agar, Gram 
staining and by standard biochemical tests.[5] ExPEC isolates 
from blood were identified  using automated biochemical 
system Vitek 2 (BioMerieux, France).
Biofilm production
The capacity to form biofilms was assayed in microtiter plates 
with minor modification as described by O’Toole and Kolter.[6] 
Briefly, cells were initially grown for 18 h in Trypticase soy 
broth (TSB) at 37°C, subsequently cultures were diluted 
1:100 with fresh TSB and 200 µl were inoculated into 96 well 
polystyrene microtiter plates and incubated for 24 h at 37°C. 
After incubation, content of each well was gently removed 
by tapping the plates. The wells were washed four times with 
200 µl of phosphate buffer saline (PBS, pH 7.2) to remove 
free‑floating planktonic bacteria. Biofilms formed by adherent 
organisms in plate were fixed with Bovin’s fixative and stained 
with crystal violet (0.1% w/v). Excess stain was rinsed off 
by thorough washing with deionized water and plates were 
kept for drying. Optical densities (OD) of stained adherent 
bacteria were determined with an ELISA reader at wavelength 
of 630 nm. These OD values were considered as an index of 
bacteria adhering to surface and forming biofilms; strains with 
mean OD values of <0.120 were considered as non‑biofilm 
producers and those with mean OD values >0.120 were 
considered to be biofilm producers. Pseudomonas aeruginosa 
ATCC 27853 was used as the control organism.
Hemolysin production
Production of α-hemolysin was tested on 5% sheep blood 
agar. E. coli strains were inoculated onto blood agar plates, 
incubated overnight at 37°C and hemolysis was detected by 
the presence of a zone of complete lysis of the erythrocytes 
around the colony.[7]
Antimicrobial susceptibility testing
Antibiotic susceptibility testing was done by the modified 
Kirby-Bauer disk diffusion method in accordance with 
CLSI guidelines.[8] The antibiotic disks (HiMedia, Mumbai) 
used were ampicillin (10 µg), piperacillin (10 µg), 
piperacillin + tazobactam (100/10 µg), ceftriaxone 
(30 µg), cefotaxime (30 µg), ciprofloxacin (5 µg), 
norfloxacin (10 µg), amikacin (30 µg), gentamicin (10 µg), 
co-trimoxazole (1.25/23.75 µg), cefoperazone + sulbactam 
(75/30 µg), imipenem (IPM; 10 µg), meropenem (MRP; 10 µg), 
and ertapenem (ETP; 10 µg).
Screening for extended spectrum of beta‑lactamase 
production
Isolates which were resistant to one or more third-generation 
cephalosporins were tested for Extended spectrum of 
beta-lactamase (ESBL) production by the combination disk 
method using, ceftazidime (30 µg) and ceftazidime/clavulanic 
acid (10 µg). A ≥5 mm increase in diameter of the inhibition 
zone of the cephalosporin-plus-clavulanate disc, when 
compared to the cephalosporin disc alone was interpreted as 
phenotypic evidence of ESBL production.[8]
Detection of AmpC production
Isolates were tested for AmpC enzyme production by AmpC 
disk test.[9] Briefly, a suspension of ATCC E. coli 25922 
standardized to 0.5 McFarland was inoculated on the surface 
of Mueller–Hinton Agar (MHA) plate. A 30 µg cefoxitin disk 
was placed on the inoculated surface of the agar. A sterile plain 
disc containing Tris-ethylenediaminetetraacetic acid (EDTA) 
inoculated with several colonies of the test isolate was placed 
beside the cefoxitin disc almost touching it, with the inoculate 
in contact with the agar surface. The plates were incubated 
overnight at 35°C, aerobically. A positive test was indicated 
as flattening or indentation of cefoxitin inhibitory zone in the 
vicinity of the test disc. A negative test had an undistorted zone.
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Detection of carbapenemase production
Plates of MHA were inoculated with suspensions of test 
strains and adjusted to a turbidity equivalent to 0.5 McFarland 
standard. A set of discs (HiMedia) of IPM, MRP, and 
ETP (10 µg each) were applied to the surface of the agar, plates 
were incubated overnight at 35°C aerobically, and diameters of 
zone of inhibition (≥23 mm indicating sensitivity, 20–22 mm 
indicating intermediate resistance and ≤19 mm indicating 
resistance) were recorded. Carbapenemase production was 
further confirmed by modified Hodge test.[8]
Detection of metallo‑β‑lactamase producers
Identification of metallo‑beta‑lactamases (MBL) activity was 
performed by two methods: A carbapenem–EDTA combined 
disk method and MBL E-test (HiMedia).[10] A known MBL 
producing isolate (PCR positive with MBL genes) was used 
as a positive control for all tests.
Determination of Escherichia coli phylogenetic groups
Isolates were assigned to one of the four main phylogenetic 
groups of E. coli (A, B1, B2, and D) by using the triplex PCR 
as described by Clermont et al.[11] Briefly, template DNA was 
obtained by boiling-lysis method. The genes chuA, yjaA and 
TSPE4.C2 were amplified using appropriate oligonucleotide 
primers.[11] The PCR was performed in a final reaction volume 
of 50 µl containing 750 mM Tris-HCl, 200 mM (NH4) 2SO4, 
2.5 mM MgCl2, 0.2 mM each of dNTP’s, 0.4 µM of each 
primers, 1 U of Taq DNA polymerase and 5 µl template DNA. 
An Eppendorf thermocycler was used for amplification. The 
program for amplification included a step of initial denaturation 
at 94°C for 5 min, followed by 30 cycles of 94°C for 30 s, 55°C 
for 30 s and 72°C for 30 s and a final extension step at 72°C 
for 7 min. The PCR products were loaded in 2% w/v agarose 
gel prepared in Tris-borate–EDTA buffer at 120V for 1 h and 
detected by ethidium bromide staining after electrophoresis.
Statistical analysis
Chi‑square test was used to find an association between the 
phylogroups, virulence factor genes and patient’s clinical 
outcome. Analysis was performed using statistical  package 
SPSS version 17.0 (USA).
Results
A total of 300 E. coli isolates from extraintestinal sources 
were collected. One hundred forty-three isolates were from 
the medical unit, 44 from surgical, 43 from urology, 20 from 
oncology, 20 from gastroenterology, 13 from obstetrics and 
gynecology, 12 from orthopedics and 5 from pediatrics units. 
The primary site of infection included 159/300 (53 %) cases 
of UTI, 77/300 (25.6%) with bacteremia, 40/300 (13.3%) 
with wound infection, 19/300 (6.3%) with pneumonia, 
3/300 (1%) intravascular device infection, and 2/300 (0.6%) 
with meningitis.
Phylogenetic analysis of isolates carried out by triplex 
PCR [Figure 1] indicated that 61/300 (20%) isolates belonged 
to Group A, 27/300 (9%) were group B1, 104/300 (35%) 
were group B2, and 108/300 (36%) belonged to group D. The 
distribution for each phylogenetic group according to gender, 
age group, site of infection, and outcome is summarized in 
Table 1. The phylogroups B2 and D occurred with greater 
frequency (statistically significant, P < 0.05) than A and 
B1 among all isolates of ExPEC without any sex disparity. 
Furthermore, phylogroups B2 and D were seen to occur at a far 
greater frequency in all age groups, when compared to A and 
B1. The largest number of ExPEC infections were observed 
in the > 60 years age group (130/300 strains; 43.3% of all 
infections, statistically significant, P = 0.04) indicating that 
this group was more susceptible than others to infection with 
ExPEC. UTI was the clinical entity wherein highest number 
of ExPEC were isolated (159/300 strains; 53% statistically 
significant, P = 0.03), again with phylogroups B2 and D 
being isolated most frequently (38.4 and 33.9% respectively, 
P < 0.01).
Regarding clinical outcome, prognosis of infections with 
strains belonging to A and B1 phylogroups was far better than 
with infections due to strains from B2 and D. Seventy-eight 
percent of cases due to ExPEC strains belonging to A and 
62.9% of cases due to infection with strains belonging 
to B1 were successfully treated and such ExPEC were 
eradicated completely with appropriate antibiotic therapy. 
On the other hand, higher morbidity (relapses and recurrent 
infections) and mortality was observed in infections due 
to ExPEC strains belonging to the virulent phylogroups 
B2 and D (37% and 26%, respectively; Table 1).
The study of phenotypic characteristics such as expression 
of virulence factors and antimicrobial resistance of the 
isolates belonging to each phylogenetic group showed 
that expression of biofilm production was greatest with 
groups B1 and B2; group B2 isolates were observed to 
be most frequently associated with hemolysin production 
(37.5%, statistically significant, P < 0.05) and 17.3% 
Figure 1: Triplex polymerase chain reaction results of phylogenetic 
grouping of extraintestinal infections isolates (phylogenetic 
group A [chu A‑, TspE4.C2−]; Group B1 [chu A−, TspE4.C2+]; 
Group B2 [chuA+, yjaA+]; and Group D [chuA+, yjaA−])
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were non-lactose fermenters [Table 2]. The expression of 
various enzymes associated with antimicrobial resistance 
and resistance patterns exhibited by isolates of the four 
phylogenetic groups against representative antimicrobials 
from different classes are shown in Table 2 and Figure 2. 
Results of our study showed that group B2 isolates produced 
the least amount of beta lactamases when compared with 
group A, B1, and D. Resistance to ciprofloxacin, norfloxacin, 
co-trimoxazole, nalidixic acid and cefoperazone/sulbactam 
was especially prevalent among group B1 isolates and 
group A isolates showed comparatively higher resistance 
to ciprofloxacin and norfloxacin when compared with 
groups B2 and D. However, in case of ampicillin and 
cefotaxime, resistance rates were higher with group B2 and 
D. The presence of multi-drug resistance (resistance to three 
or more antibiotic groups) strains were significantly higher 
in group B1 isolates (statistically significant, P = 0.04). 
Among the four groups, A and B1 group isolates were most 
frequent β-lactamase (ESBL, AmpC, Carbapenemases, 
MBL) producers when compared to group B2 and 
D [Table 2].
Discussion
Escherichia coli is emerging as an important cause of 
extraintestinal infections in our hospitals. These strains are seen 
to exhibit several virulence properties as well as a high rate of 
antibiotic resistance which is of major concern for management 
of cases. Extraintestinal pathogenic E. coli which routinely 
cause infections have been shown to belong to phylogroups B2 
and D.[2,3] Results of our study indicated that approximately 
70.6% of the E. coli isolates from our patients also belonged 
to phylogenetic group B2 and D which is in agreement with 
previous findings.[3,4] The least frequently isolated phylogenetic 
group in our study was group B1, which is also in accordance 
with similar studies done elsewhere.[4]
Our study on the prevalence of different phylogroups in 
various clinical entities yielded the following facts: In cases 
of sepsis among our study population, we found that all four 
phylogroups occurred with approximately equal frequency 
whereas in other studies, groups B2 and D have been reported 
to be more common.[4,12] However, in cases of UTI, B2, 
Table 1: Comparison of different phylogenetic groups of ExPEC in relation to demographical features and clinical outcome
Feature Phylogenetic groups (n=300) Total (%)
A B1 B2 D
Gender
Male 35 14 56 58 163 (54.3)
Female 26 13 48 50 137 (45.6)
Age
>1 ‑ 1 2 1 4 (1.3)
1‑18 ‑ ‑ 5 3 8 (2.6)
19‑44 15 9 20 27 71 (23.6)
45‑59 18 10 32 27 87 (29)
>60 28 7 45 50 130 (43.3)#
Infection
UTI 27 17 61 54 159 (53)¥
Sepsis 16 7 27 27 77 (25.6)
Wound 8 2 13 17 40 (13.3)
Pneumonia 9 ‑ 3 7 19 (6.3)
Meningitis ‑ 1 ‑ 1 2 (0.6)
Outcome
Improved 48 17 62 75 202 (67.3)
Re‑infection 4 6 28 17 55 (18.3)
Expired 8 2 12 11 33 (11)
Lost to follow‑up 1 2 2 5 10 (3.3)
Total* n (%) 61 (20.3) 27 (9) 104 (34.6)@ 108 (36)@ 300 (100)
*Numbers represent total number of each phylogenetic group in each category; that is, a, b, c and d. Among 300 isolates #Statistically significant, P=0.04, ¥Statistically significant P=0.03, 
Among the phylogroup @Statistically significant, P<0.05. UTI: Urinary tract infection
Figure 2: Antimicrobial resistance (in percentage) to representatives 
from different classes of antibiotics among 300 Escherichia coli isolated 
from various extraintestinal sources (CIP: Ciprofloxacin, NX: Norfloxacin 
GEN: Gentamicin, AK: Amikacin, NA: Nalidixic acid, COT: Co‑trimoxazole. 
CFS: Cefoperazone/sulbactam. CTX: Cefotaxime., AMP: Ampicillin)
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and D phylogroups were more common. The most common 
phylogroup which was responsible for relapses and/or deaths 
was group B2, which probably indicates the capability of 
strains of this group to cause persistent and severe infections.
Previous studies have indicated that phylogroups B2 and D 
possess more virulence properties such as biofilm formation 
and hemolysin secretion when compared with phylogroups A 
and B1 isolates.[13,14] In our study, we found group B2 consisted 
of a greater number of non-lactose fermenting isolates, and 
also more strains produced hemolysin which is considered 
to be a potent virulence factor essential for survival in 
extraintestinal sites.[3,13] Interestingly, it was group B1 isolates 
which expressed a higher capacity to form biofilms, a virulence 
factor which has been shown to be responsible for the initial 
step of adherence to various cell/tissue surfaces, during the 
process of infection.[14]
Regarding antimicrobial resistance exhibited by isolates 
from different phylogroups, our study results indicated that 
phylogroup B2 isolates were the most susceptible (statistically 
significant) to antibiotics than isolates belonging to the other three 
groups. Similar results have been obtained by other investigators, 
indicating that although being more virulent, the isolates of 
phylogroup B2 were more susceptible to antibiotics.[12] However, 
in our study, we found gentamicin resistance was more common 
in group B2 isolates. Several studies have reported a significant 
association of ciprofloxacin–resistant extraintestinal E. coli 
with phylogeny group A and ciprofloxacin susceptibility with 
group B2, which is similar to our study findings.[15,16]
Our study of the ability of isolates to produce antimicrobial 
degrading enzymes such as ESBLs, AmpC, carbapenemase, 
and MBLs indicated that beta lactamase producing isolates 
occurred with greater frequency in group A and B1 isolates 
when compared with B2 and D, a finding which is in 
accordance with other studies.[15,17] This finding indicates that 
strains belonging to phylogroups A and B1 were carrying 
more resistance properties than the strains belonging to 
phylogroups B2 and D. By this finding, it may be assumed that 
in our population a large number of people act as a reservoir 
for such resistant strains. This may be due to inappropriate 
antibiotic use in both animals and humans.
Conclusion
Results of our study indicate that pathogenic strains belonging 
to phylogenetic groups B2 and D express more virulent 
properties but were seen to be more susceptible to antibiotics 
than phylogroups A and B1 isolates. This finding indicates a 
need for regular monitoring of antimicrobial susceptibility in 
commensal strains as these strains might transfer the property 
of antimicrobial resistance to pathogenic strains. There is also 
an urgent need to undertake measures which would prevent 
the development of multidrug resistance among commensal 
strains such as reducing inappropriate antibiotic treatment, the 
overuse of antimicrobials in the agricultural industry which 
might contribute to increased numbers of multidrug resistant 
strains. Clearly, antimicrobial resistance may lead to decreased 
therapeutic outcomes in the near future.
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